IP-Watch Geneva IP Delegates List Updated 17/03/2015 by Intellectual Property Watch, Intellectual Property Watch Leave a Comment Intellectual Property Watch offers a partial list of the government delegates in Geneva with responsibility for intellectual property issues at the United Nations and World Trade Organization. The newly updated list is now available, exclusively for subscribers. [Note: IP-Watch content is free to most developing countries, just register online here]
UN Human Rights Council Debates Report Criticising Copyright 11/03/2015 by Catherine Saez, Intellectual Property Watch 13 Comments Copyright might run counter to human rights, says a new report from the United Nations Special Rapporteur in the field of cultural rights. In the report, she provides a number of recommendations, including encouraging UN World Intellectual Property Organization members to support the adoption of international instruments on limitations and exceptions to copyright. The report is under consideration by the Human Rights Council and was debated extensively today.
Why The Request By Least Developed Countries For An Extension Of The Transitional Period For Granting And Enforcing Medicines Patents Needs To Be Supported 27/02/2015 by Intellectual Property Watch 2 Comments Ellen ‘t Hoen writes: On 24 February 2015 Bangladesh on behalf of the 34 Least Developed Country members (LDCs) of the World Trade Organization (WTO) submitted a request for an extension of the transitional period under article 66.1 TRIPS with respect to pharmaceutical products until the country is no longer classified as LDC.[1] The original extension, set to expire on 1st January 2016, specifically removes the obligation for LDCs to comply with Section 5 (Patents) and Section 7 (Protection of Undisclosed Information) of Part II of TRIPS, including any obligation to enforce rights under these provisions. It is a little known fact that since the adoption of the 2001 Doha Declaration on TRIPS and Public Health, LDCs have frequently used the extension in day-to-day procurement of low cost generic medicines, in particular to access medicines needed for the treatment of HIV.
Ebola Crisis Has Severe Impact On AIDS Response In Sierra Leone, UNDP Report Says 27/02/2015 by Catherine Saez, Intellectual Property Watch Leave a Comment According to an internal report of the United Nations Development Programme (UNDP) Global Fund Partnership team, the Ebola epidemic has virtually halted national HIV efforts in Sierra Leone. In particular, patients stopped their treatments and the supply chain was disrupted.
New Quiet Initiative To Improve Drug Access In Middle-Income Countries, Change Country Classification System 25/02/2015 by Catherine Saez, Intellectual Property Watch 2 Comments This week a confidential high-level expert meeting was convened in Geneva to start work on a potential change in the country classification used by global health actors to remedy the growing problem of access to medicines in middle-income countries.
In 21st Century No One Should Die For Lack Of Access To Medicines, Participants At UN Forum Say 23/02/2015 by Catherine Saez, Intellectual Property Watch Leave a Comment Last week’s 2015 Social Forum led by the UN Office of the High Commissioner for Human Rights (OHCHR) called for urgent action to facilitate access to medicines. In particular, the functioning of the intellectual property system was put into question. A number of recommendations were drawn by the secretariat after having been identified by participants.
TRIPS In Question During Social Forum Discussion On Access To Medicines 23/02/2015 by Catherine Saez, Intellectual Property Watch Leave a Comment Intellectual property rights are hindering access to medicines by maintaining monopolies and high prices, according to speakers at an annual United Nations forum on human rights last week. Flexibilities enshrined in the World Trade Organization intellectual property agreement are hampered by political and economical pressure, they said, and a new system should be devised for pharmaceutical products.
Geneva Climate Change Talks Conclude With Formal Negotiating Text 13/02/2015 by Elena Bourtchouladze for Intellectual Property Watch Leave a Comment Following seven days of negotiations, 194 nations convened in Geneva agreed the negotiating text that is the basis for the accord they hope to reach in Paris at the end of 2015, to come into effect in 2020.
Biosimilars Present Opportunity, Challenge For Developing Countries, UNCTAD Group Says 23/01/2015 by Catherine Saez, Intellectual Property Watch 3 Comments Biosimilars are a hot topic. Beyond the colossal profits foreseen by some, drawing a lot of interested parties into the game, developing countries mean to play a role in this new frontier. However, biosimilars – close copies of biopharmaceutical products – are difficult and very costly to produce and come as a challenge to the generic industry used to duplicating small molecules. And some warn about differences in regulatory requirements, which could effectively boot developing countries out of the global market.
Most-Read IP-Watch Stories In 2014: A Tale Of Staff Issues, India, Hot-Button Topics 07/01/2015 by William New, Intellectual Property Watch 1 Comment All year long, Intellectual Property Watch expends great energy and resources to bring hundreds of carefully written, detailed stories on policymaking – technical committee meetings, legislation, negotiations, legal cases, and latest reports and papers. But in what is perhaps typical of readers everywhere, many of the best-read IP-Watch stories of 2014 were those few that involved elections and personnel issues and India, followed by a range of hot button issues such as high-priced medicines, copyright and knowledge access, patent valuation, or internet surveillance.